Diabetes, Hypertension Clinical Trials

Cedar Crosse Research Center is now actively seeking patient volunteers to enroll in our ongoing clinical trial opportunities. Presently, we are conducting clinical trials for patients with diabetes, hypertension, or migraines in addition to vaccine trials. The duration of these clinical trials varies but there is no cost to the patient for participation. Study patients may be compensated for their time and travel along with potentially receiving medical management management supplies during the course of the clinical trial.

If you suffer from diabetes, hypertension, obesity, or migraines, do not hesitate to contact us via phone or email.

COVID-19 TESTING NOW AVAILABLE

As an Illinois Department of Public Health COVID-19 testing facility, Cedar Crosse Research Center is pleased to offer COVID-19 testing – Rapid Testing (BD Antigen Test), Molecular PCR testing and antibody testing. Please click the link below, “Book Online” to make an online appointment or call us for additional information at 312-431-6780.

DIABETES RESEARCH TRIAL

Currently recruiting type 2 diabetic patients for clinical trial opportunities.

-Subjects ages 18 to 75 years old.

-Stable daily doses of oral medications 90 days prior to screening.

-Hemoglobin A1c of 7-10%

-Also seeking subjects with a history of type 2 diabetes and cardiovascular events

COVID-19 VACCINE TRIAL

Patients needed for COVID-19 vaccine trial with Novavax, a biotechnology company developing next-generation vaccines for serious infectious diseases - Phase 3 clinical development program of NVX-CoV2373, its COVID-19 vaccine candidate. NVX‑CoV2373 is a stable, prefusion protein made using Novavax nanoparticle technology.

To qualify:
-Adults 18 years of age or older who by virtue of age, race, ethnicity or life circumstances are considered at substantial risk of exposure to and infection with SARS-CoV-2.

Study participants will be compensated for time and travel.

DO YOU HAVE HYPERTENSION?

Patients between the ages of 18 - 75 years old with high blood pressure.

-Poorly controlled hypertension.

-Use of a stable dose of hypertensive medications

ARE MIGRAINES CONSTANTLY ON YOUR MIND?

ARE MIGRAINES CONSTANTLY ON YOUR MIND?
A RESEARCH STUDY IS BEING CONDUCTED FOR PEOPLE EXPERIENCING MIGRAINES

Inclusion Criteria:

- Males and females between 18 and 65 years of age, inclusive, who were diagnosed with migraines at ≤ 50 years of age, and have a history of chronic migraine for ≥ 12 months before screening.

Exclusion Criteria:

- Confounding and clinically significant pain syndromes (e.g. fibromyalgia, chronic low back pain, complex regional pain syndrome).
- Psychiatric conditions that are uncontrolled and/or untreated, including conditions that are not controlled for a minimum of 6 months prior to screening. -
- Psychiatric conditions that are uncontrolled and/or untreated, including conditions that are not controlled for a minimum of 6 months prior to screening.
- History or diagnosis of complicated migraine (ICHD-III beta version, 20134), chronic tension-type headache, hypnic headache, cluster headache, hemicrania continua, new daily persistent headache, or sporadic and familial hemiplegic migraine.
- Receipt of any monoclonal antibody treatment (within or outside a clinical trial) within 6 months before screening.

Call: (312) 431-6780

Email: info@cedarcrosse.com

Cedar Crosse Research Center

1996

The year Dr. Danny Sugimoto founded Cedar Crosse Research Center to make meaningful improvements in the lives of others through clinical research trials.

450+

Number of clinical trials completed with a multi-specialty therapeutic expertise including diabetes, hypertension, obesity, COPD, migraines, hyperlipidemia, etc.

14

Average cycle time in days from IRB submittal to IRB approval.

principles
of research

Care

A personalized, patient centered perspective in all clinical tasks.

Compliance

Strictly adhering to GCP and FDA regulatory procedures to quality date collections.

Compassion

Uniting with patients to improve lives.

100%
Randomization Rate

Contact

Contact us to request additional information or to make an appointment